Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

Garrelfs, SF; Metry, EL; van Harskamp, D; Vaz, FM; van den Akker, CHP; Schierbeek, H; Groothoff, JW; Oosterveld, MJS

Metry, EL (通讯作者),Room H8-253,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.

KIDNEY INTERNATIONAL, 2023; 103 (5): 990